Spruce Biosciences
USEntry
2020
Hold
<1yr
Exit
2020
Who owns Spruce Biosciences?
Spruce Biosciences was owned by Abingworth through Abingworth Bioventures VII (2018 vintage) from 2020 to 2020, exited via IPO.
Hand-verified · updated 2026-05-21
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2020
More from Abingworth Bioventures VII
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Spruce Biosciences
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Spruce Biosciences?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Spruce Biosciences.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue